Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The Growth Hormone-Releasing Hormone Receptor (GHRHR) is a Class B G protein-coupled receptor primarily expressed in the anterior pituitary gland. It mediates the effects of growth hormone-releasing hormone (GHRH), stimulating the synthesis and release of growth hormone. GHRHR plays a critical role in growth, metabolism, and development. Mutations in GHRHR can lead to isolated growth-hormone deficiency (IGHD). Dysregulation or overexpression of GHRHR has been implicated in various cancers, making it a potential therapeutic target for antagonists.
Agonist binding activates Gs protein, leading to increased cAMP production and GH synthesis/release. Antagonists block GHRH binding, inhibiting downstream signaling.
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Growth Hormone-Releasing Hormone Receptor (GHRHR).